Global Health Ltd (MEDANTA)
₹1,424.20
Mkt cap
₹39,519 Cr
P/E ratio
69.00
P/B
9.69
Div yield
0.03%
ROE
15.20%
ROCE
17.40%
EPS (TTM)
₹20.64
Book value
₹147
52W range
961–1,509
Sector
Healthcare
Price history
Previous close
Global Health Limited is one of the largest private multi-specialty tertiary care providers operating in the North and East regions of India. The company has key specialties in cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopedics, liver transplant, and kidney and urology. [1]
NSE MEDANTABSE 543654
Health check
Constructive
ValuationExpensive
ProfitabilityStrong
GrowthModerate
TechnicalsBullish
52-week range
−5.61% from high₹1,424
₹961+48.18% from low₹1,509
Current
₹1,424.20
Prev close
₹1,478.00
Day
−3.64%
Price performance
1D
−3.64%
1W
−3.75%
1M
−2.16%
3M
+14.66%
6M
+28.34%
1Y
+2.02%
YTD
+17.02%
Financials
Revenue, profit & margin
P/E ratio
69.0×
MEDANTA is 40% above the sector median of 49.1×
MEDANTA69.0×
Sector median49.1×
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 780 | 844 | 836 | 809 | 861 | 957 | 943 | 931 | 1,031 | 1,099 | 1,121 | 1,159 | 1,304 | |
| Expenses | 595 | 631 | 620 | 629 | 675 | 728 | 706 | 707 | 784 | 868 | 904 | 915 | 1,017 | |
| Operating Profit | 184 | 213 | 216 | 179 | 186 | 228 | 238 | 225 | 247 | 231 | 217 | 244 | 287 | |
| OPM % | 24% | 25% | 26% | 22% | 22% | 24% | 25% | 24% | 24% | 21% | 19% | 21% | 22% | |
| Other Income | 15 | 21 | 18 | 27 | 22 | 18 | 16 | -27 | 20 | 36 | -15 | 37 | 22 | |
| Interest | 18 | 20 | 18 | 18 | 18 | 16 | 16 | 15 | 14 | 17 | 22 | 27 | 27 | |
| Depreciation | 40 | 43 | 44 | 45 | 47 | 49 | 48 | 49 | 45 | 50 | 61 | 67 | 69 | |
| Profit before tax | 141 | 171 | 172 | 143 | 144 | 181 | 189 | 133 | 208 | 200 | 120 | 187 | 213 | |
| Tax % | 28% | 27% | 28% | 11% | 26% | 28% | 24% | 24% | 24% | 21% | 21% | 24% | 26% | |
| Net Profit | 102 | 125 | 124 | 127 | 106 | 131 | 143 | 101 | 159 | 158 | 95 | 142 | 157 | |
| EPS in Rs | 3.80 | 4.66 | 4.61 | 4.74 | 3.96 | 4.87 | 5.32 | 3.78 | 5.92 | 5.89 | 3.54 | 5.36 | 5.90 | |
| Raw PDF |
Earnings
Results dates & reactionsNo upcoming results date on calendar.
Fresh quarters land in the Financials table above, tagged NSE until screener catches up.
Avg earnings-day move +0.72% · closed higher next day 10 of last 15
| Q2FY24 | Q3FY24 | Q4FY24 | Q1FY25 | Q2FY25 | Q3FY25 | Q4FY25 | Q1FY26 | Q2FY26 | Q3FY26 | Q4FY26 | Q1FY27 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Broadcast | 9 Nov '23◦ | 8 Feb '24◦ | 17 May '24◦ | 8 Aug '24◦ | 14 Nov '24◦ | 4 Feb '25◦ | 15 May '25◦ | 7 Aug '25◦ | 7 Nov '25◦ | 4 Feb '26◦ | 14 May '26◦ | 30 Jul '26◦ |
| Earnings day | +5.01% | +0.85% | −1.20% | −3.44% | +0.83% | +10.73% | −3.39% | +7.25% | −5.42% | −1.34% | +2.52% | −0.76% |
| +1 day | +5.94% | +6.96% | −6.05% | −7.85% | +1.86% | +12.23% | −5.01% | +4.55% | −6.30% | +1.77% | +2.25% | +2.01% |
| +5 days | +4.32% | +14.04% | −13.93% | −5.77% | +2.82% | +4.67% | −1.88% | +1.22% | −3.97% | +2.30% | +2.16% | +2.77% |
| +15 days | +16.72% | +3.16% | −14.68% | −3.77% | +6.46% | +14.60% | −2.19% | +4.78% | −0.47% | +3.46% | −0.12% | −0.47% |
| +30 days | +11.27% | +2.49% | −10.27% | −6.61% | +2.68% | +21.51% | −8.74% | −0.40% | −6.68% | −10.43% | +8.41% | — |
| Filing | XBRL | XBRL | XBRL | XBRL | XBRL | XBRL | XBRL | XBRL | XBRL | XBRL | XBRL | XBRL |
Corporate actions
Last 6 monthsNo recent corporate actions
Dividends, splits, and bonuses in the last six months show up here.
Shareholding
as of Jun 202633.00%Promoter
Promoters33.00%
FIIs9.46%0.69
DIIs16.89%2.13
Public40.55%1.46
Ownership trend
Peers
7 companiesValuation vs quality
P/E × ROCE · bubble = market cap| Name | CMP | P/E | Mkt Cap | Div Yld | NP Qtr | Qtr Profit Var | Sales Qtr | Qtr Sales Var | ROCE |
|---|---|---|---|---|---|---|---|---|---|
| APOLLOHOSP | ₹8,650.00 | 59.12 | 1,24,374 | 0.23% | 610 | +34.17% | 7,044 | +20.56% | 17.45% |
| MAXHEALTH | ₹984.80 | 64.02 | 95,852 | 0.20% | 323 | +4.87% | 2,366 | +16.70% | 14.71% |
| MANIPALHOS | ₹725.20 | 107.73 | 95,391 | 0.00% | 243 | −7.86% | 3,091 | +38.12% | 12.10% |
| ASTERDM | ₹785.75 | 189.76 | 68,492 | 0.38% | 29 | −46.12% | 1,311 | +21.60% | 11.40% |
| FORTIS | ₹905.00 | 64.04 | 68,324 | 0.11% | 273 | +3.39% | 2,545 | +17.46% | 13.45% |
| MEDANTA | ₹1,469.80 | 69.02 | 39,519 | 0.03% | 157 | −0.18% | 1,304 | +26.50% | 17.37% |
| NH | ₹1,858.50 | 44.06 | 37,980 | 0.24% | 207 | +5.71% | 2,684 | +78.05% | 15.50% |
| Median: 29 Co. | ₹514.10 | 49.13 | 6,632 | 0.03% | 31 | +18.98% | 406 | +22.28% | 14.71% |
Filings
Concall transcripts38
TranscriptAug 2026PPTAug 2026RECAug 2026TranscriptMay 2026PPTMay 2026RECMay 2026TranscriptFeb 2026PPTFeb 2026RECFeb 2026TranscriptNov 2025PPTNov 2025RECNov 2025TranscriptAug 2025PPTAug 2025TranscriptMay 2025PPTMay 2025PPTMay 2025TranscriptFeb 2025PPTFeb 2025RECFeb 2025TranscriptNov 2024PPTNov 2024TranscriptAug 2024PPTAug 2024
Credit ratings6
Announcements5
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 3 Sep - Global Health schedules one-on-one investor meetings with Polar Capital and Chikara Investments on September 10 and 14, 2026.Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 3 Sep - Announcement under SEBI Listing Regulations regarding schedule of Institutional Investor meet.Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 31 Aug - Announcement under SEBI Listing Regulations regarding schedule of Institutional Investor meet.Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 31 Aug - Global Health to meet Matthews International Capital Management and Baillie Gifford on September 8, 2026 in Gurugram.Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 25 Aug - Global Health to meet investors/analysts on August 31, 2026 in Noida.